Hello, everyone, and welcome to the working week. We hope the weekend was relaxing, although we know that some of you spent some time coping with the blizzard in the Northeast. Of course, that is history now, which means it is time to forge ahead and get ready for another stretch of meetings and deadlines and whatever else is on your to-do list. Ours is especially long, in fact. So time to get started. As always, here are some tidbits to pave the way. Hope your day goes well and do stay in touch...
Sanofi Plans To Raise Its Stake In Regeneron (Bloomberg News)
Glaxo Will Keep Its Consumer Business (The Telegraph)
Perrigo Buys Rosemont Pharmaceuticals For $283M (MLive)
Celgene Wins FDA OK For Multiple Myeloma Drug (Bloomberg News)
Sun Pharma And Taro Pharma Merger Falls Through (Pharma Times)
Merck Banks On An Insomnia Pill After Setbacks (The Star-Ledger of NJ)
Pfizer Layoffs At Groton Site Are Larger Than Expected (The Day)
US Pharma Exports To Iran Cut In Half In 2012 (Reuters)
Tranzyme Considers Sale After Trial Failures (Pharma Times)
Shire And Impax Settle Generic Adderall XR Lawsuits (Associated Press)
EDITOR'S NOTE: Please check this post for additional items during the day
rain pic thx to sterlic on flickr
1 Comment
Go Teva...